United Therapeutics Stocks List

Related ETFs - A few ETFs which own one or more of the above listed United Therapeutics stocks.

United Therapeutics Stocks Recent News

Date Stock Title
May 6 UTHR United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?
May 6 VERA Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week
May 4 ASND Ascendis Pharma A/S (ASND) Q1 2024 Earnings Call Transcript
May 4 ASND Ascendis Pharma First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 3 UTHR 30 Most Profitable Companies with Highest Margins in the World
May 2 ASND Ascendis Pharma reports Q1 results
May 2 ASND Ascendis Pharma Reports First Quarter 2024 Financial Results
May 2 UTHR United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
May 2 UTHR United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
May 2 UTHR United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
May 2 UTHR Q1 2024 United Therapeutics Corp Earnings Call
May 1 ASND Ascendis Pharma Q1 2024 Earnings Preview
May 1 UTHR Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
May 1 UTHR United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript
May 1 UTHR Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics
May 1 UTHR United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
May 1 UTHR United Therapeutics GAAP EPS of $6.17 beats by $0.51, revenue of $677.7M beats by $53.51M
May 1 UTHR United Therapeutics Corporation Reports First Quarter 2024 Financial Results
Apr 30 UTHR United Therapeutics Q1 2024 Earnings Preview
Apr 30 SKYE Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
United Therapeutics

United Therapeutics Corporation is an American publicly traded biotechnology company listed on the NASDAQ under the symbol UTHR. Its mission is to develop novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville Florida; La Jolla, California; and Manchester, New Hampshire.

Browse All Tags